Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -6,910 | -4,440 | -1,370 |
| Depreciation Amortization | 2,580 | 1,490 | 470 |
| Other Working Capital | 140 | 100 | 210 |
| Other Operating Activity | 1,630 | 1,130 | 200 |
| Operating Cash Flow | $-2,560 | $-1,720 | $-490 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -10 | -10 | -10 |
| Investing Cash Flow | $-10 | $-10 | $-10 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 2,930 | 2,320 | 550 |
| Financing Cash Flow | $2,930 | $2,320 | $550 |
| Beginning Cash Position | 10 | 10 | 10 |
| End Cash Position | 360 | 600 | 50 |
| Net Cash Flow | $350 | $590 | $40 |
| Free Cash Flow | |||
| Operating Cash Flow | -2,560 | -1,720 | -490 |
| Free Cash Flow | -2,560 | -1,720 | -490 |